$8 Million Pharmacy NNN Acquisition in Denver
By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions
An $8 million pharmacy net lease acquisition in Denver represents a stable, institutional-grade investment anchored by a national or regional credit tenant on a long-term triple-net lease. Lenders in this category typically offer 60 to 75 percent LTV depending on tenant strength and remaining lease term, with rates around 6.25 percent reflecting current CMT-based pricing for investment-grade single-tenant deals. Denver's strong demographic fundamentals and consistent pharmacy demand make these deals attractive to both debt funds and traditional banks, particularly for 1031 exchange investors seeking passive income replacement. The $8 million loan size sits comfortably within most lender sweet spots, commanding efficient pricing and broad capital availability.
Get a Quote on Your $8M Deal →What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like
National and regional banks with established single-tenant net lease programs dominate the capital stack at this loan size in Denver. Lender selection typically turns on tenant credit rating, lease remaining term, and sponsor experience; investment-grade pharmacies on 10-plus-year leases can access the most competitive terms, while smaller regional operators or shorter lease horizons may require life company or credit union financing. Most deals close non-recourse at lower LTV, making sponsor balance sheet less of a constraint than asset quality.
Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.
Who Closes a $8M Pharmacy NNN Acquisition Deal
Typical sponsors for $8 million pharmacy acquisitions in Denver range from established 1031 exchange investors with $3 million to $5 million net worth seeking passive long-term hold to smaller regional operators with 5 to 15 prior deal closings looking to acquire a second or third location. Many are former owners transitioning from operations to investment, or experienced CRE investors looking to redeploy capital into triple-net pharmacy income. Common motivations include tax-deferred exchanges, portfolio diversification away from office or retail, and the appeal of tenant-responsible maintenance and capex.
A Real $8M Example
We closed an $7.2 million pharmacy acquisition in the Aurora submarket for a regional investor with prior single-tenant experience. The property carried an investment-grade tenant on a 12-year lease with 5-year renewal options, generating 6.1 percent cap rate. A regional bank offered 70 percent LTV at 6.25 percent fixed on a non-recourse basis, closing in 52 days with minimal sponsor recourse beyond a typical bad-boy carve-out. The investor's 1031 exchange timeline was tight, but lender's streamlined underwriting and existing knowledge of the tenant credit allowed fast pre-approval and appraisal ordering, enabling the deal to fund before the exchange deadline.
Anonymized. All deal references protect borrower and lender identity.
$8M Pharmacy NNN Acquisition Denver FAQ
Get a Quote on Your $8M Deal
Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.
Apply for Financing →